NEPHROTOXICITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR AND NSAID THERAPY

被引:35
|
作者
SEELIG, CB
MALOLEY, PA
CAMPBELL, JR
机构
[1] UNIV NEBRASKA,MED CTR,COLL MED,DEPT INTERNAL MED,OMAHA,NE 68105
[2] UNIV NEBRASKA,COLL PHARM,DEPT PHARM PRACTICE,OMAHA,NE 68182
关键词
D O I
10.1097/00007611-199010000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-I converting enzyme (ACE) inhibitors and nonsteroidal anti-inflammatory drugs (NSAIDs) can be nephrotoxic and may synergistically compromise renal function. A computer-assisted study was done to assess the prevalence of compromised renal function and the clinical importance of this drug interaction. A search of the records of all patients seen in the University of Nebraska Medical Center Internal Medicine Clinic was conducted to identify cases involving renal insufficiency, therapy with ACE inhibitors, or therapy with NSAIDs. Records of cases meeting these criteria were reviewed for clinical correlation and revealed 2278 patients treated with NSAIDs, 328 with ACE inhibitors, and 162 with both. No nephrotoxicity was found in conjunction with monotherapy, but three cases of reversible renal failure were found in conjunction with combination therapy. Significant nephrotoxicity during the concomitant use of ACE inhibitors and NSAIDs is not uncommon, and attention should be drawn to this potentially important interaction. © 1990 Southern Medical Association.
引用
收藏
页码:1144 / 1148
页数:5
相关论文
共 50 条
  • [1] EXTREME HYPERKALAEMIA CAUSED BY CONCOMITANT USE OF A NSAID AND AN ACE INHIBITOR IN AN ELDERLY PATIENT
    Rogulj, Dinko
    Hauptfeld, Marko
    Iskra, Mojca Savnik
    Zorko, Vanda Kostevc
    Strasek, Milena
    ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY, 2010, 61 (02): : 241 - 245
  • [2] LDL-APHERESIS AND CONCOMITANT ACE-INHIBITOR THERAPY
    SINZINGER, H
    BEDNAR, J
    GRANEGGER, S
    BLAZEK, I
    PESKAR, BA
    ATHEROSCLEROSIS, 1994, 105 (01) : 115 - 116
  • [3] ADDITIVE ANTIPROTEINURIC EFFECT OF THE NSAID INDOMETHACIN AND THE ACE INHIBITOR LISINOPRIL
    HEEG, JE
    DEJONG, PE
    VRIESENDORP, R
    DEZEEUW, D
    AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 : 94 - 97
  • [4] ACE inhibitor therapy is associated with a decreased incidence of colorectal cancer
    Makar, George
    Lewis, James D.
    Yang, Yu-Xiao
    GASTROENTEROLOGY, 2006, 130 (04) : A101 - A101
  • [5] Concomitant coumarin-NSAID therapy and risk for bleeding
    Knijff-Dutmer, EAJ
    Schut, GA
    van de Laar, MAFJ
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (01) : 12 - 16
  • [6] Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications
    Jonasson, Christian
    Hatlebakk, Jan G.
    Lundell, Lars
    Kouri, Jukka P.
    Andersen, Morten
    Granath, Fredrik
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (05) : 531 - 538
  • [7] NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
    Annie, Frank H.
    Bates, Mark
    Embrey, Sarah
    Alkhouli, Mohamad
    Bhatt, Deepak
    Misenheimer, Jacob
    George, Hannah
    Gwinn, Ronald
    Nanjundappa, Aravinda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3076 - 3076
  • [8] ACE inhibitor therapy: Benefits and underuse
    Smith, SC
    AMERICAN FAMILY PHYSICIAN, 1999, 59 (01) : 35 - +